window.dataLayer = window.dataLayer || []; function gtag(){dataLayer.push(arguments);} gtag('js', new Date()); gtag('config', 'G-4PR1PSYQLJ'); Skip to content

Welcome to Discover Pharma! Today is : April 29, 2026

  • News
  • Featured News Archives
    • 12 Days of Christmas
    • Women in Pharma
  • About Us
Contact Us

Biotech Innovation

  • Clinical Trials,Healthcare leadership,Women in Pharma

    Strong scientists: PHARMExcel’s Margaret Irwin on clinical research careers and early stage trials

    From hospital haematology to leading early stage clinical trials, Margaret [...]

    March 10, 2026
  • Artificial Intelligence,CDMOs & Manufacturing,Data Management,Peptides,Research & Development

    Solvias CSO Danny Galbraith on peptides, ADCs and AI driving drug development innovation

    Discover Pharma caught up with Danny Galbraith, chief scientific officer [...]

    November 7, 2025
  • Biotech,Clinical Development,Clinical Trials,Drug Development,Global health,Partnerships & Funding,Rare Diseases,Research & Development

    SeaBeLife secures €2 million to advance dual-targeted therapies for dry AMD and severe acute hepatitis

    SeaBeLife, a biotechnology company developing novel drug candidates to block [...]

    October 1, 2025
  • Biologics & Biosimilars,CDMOs & Manufacturing,Drug Development,European biotech,Partnerships & Funding,Supply Chain & Logistics

    Ofichem expands drug substance capabilities with acquisition of Meribel Pharma Solutions’ Uppsala site in Sweden

    Acquisition enhances innovation offering and expands biotech footprint across Nordic [...]

    July 29, 2025
  • CDMOs & Manufacturing,Cell & Gene Therapy,Drug Development

    ReiThera to showcase AAV breakthroughs and expand US reach

    May 13, 2025
  • Cell & Gene Therapy,Technology and platforms

    Title21 appoints expert committee to support cell and gene therapy platform development

    May 7, 2025
  • Biologics & Biosimilars,Drug Development

    Molecular Devices unveils automated QPix FLEX system to transform microbial colony picking

    New benchtop platform boosts speed, sterility, and accuracy for microbiology [...]

    May 7, 2025
  • Clinical Trials

    Novadip’s ‘off-the-shelf’ spine fusion product shows early efficacy and safety in studies

    April 24, 2025
  • Cell & Gene Therapy

    Cellistic unveils Echo-NK platform to scale up iPSC-based cell therapies

    April 22, 2025

Bringing you the latest industry news and insights every day

Registered Address: Discover Pharma Ltd, 1 Dartmouth Close, Brighton, BN2 4HZ, UK
Company Number: 16239596

  • About Us
  • Contact Us
  • Legal
    • Cookie Policy
    • Privacy Policy
    • Terms & Conditions
  • Author Guidelines
    • Pharmaceutical Author Guidelines
    • Press Release Advice
  • Advertise with Us
  • Media Kit Request

© 2026 Discover Pharma. All rights reserved • Developed by Hairy Goat Design

Page load link

Press “ESC” key to close

main menu
  • Home
  • News
  • About Us
  • Contact
recent posts
  • ISS National Lab research advances DNA-inspired cancer nanomaterials for chemotherapy and immunotherapy development
    Categories: Drug Delivery & Formulation, Drug Development, Oncology, Pharmaceuticals and therapeutics, Research & Development, Technology and platforms
  • Neomorph raises $100 million to advance NEO-811 Phase 1/2 cancer trial and molecular glue degrader pipeline
    Categories: Biotech, Clinical Trials, Drug discovery, Funding, Oncology, Partnerships & Funding, Pharmaceuticals and therapeutics, Research & Development, Technology and platforms
  • NICE expands Lokelma access for hyperkalaemia after draft recommendation
    Categories: Cardiovascular diseases, Chronic diseases, Market Access & Commercialization, Pharmaceuticals and therapeutics, Regulatory Affairs
get connected
This website uses cookies and third party services. See our Cookie Policy and Privacy Policy pages for details. OK
Go to Top